Since purchasing i see the landscape far more competitive, the claims of advantage (30 day protection) questioned (by Medicines and Healthcare Products Regulatory Agency, which is after the company has said this has been verified by laboratories across the world) and deflection rather than education from PH regarding peoples concerns in multiple interviews.
To go from update to update about sales and contracts and now suddenly not a peep as well as paying a measly dividend to perhaps appease the funds he sold his large stake to doesn't sit quite right for me either.
In saying that i think the move into the Chinese market is brilliant and they seem to be pursuing that opportunity with purpose and efficiency, which i commend them on.
However the risk/reward just doesn't stack up any more for me, at least at these levels. Happy to be proven wrong and i wish everyone holding the best of luck.
ZNO Price at posting:
$2.02 Sentiment: Sell Disclosure: Not Held
